Hemispherx BioPharma leads Tuesday's top movers in healthcare Print E-mail
By BiomedReports Staff   
Tuesday, 02 June 2009 16:42
Hemispherx Biopharma, Inc. (AMEX:HEB), the company, engaging in the
development, manufacture, marketing, and distribution of new drug therapies for the

Error. Page cannot be displayed. Please contact your service provider for more details. (31)

treatment of viral and immune based chronic disorders led all stock in healthcare on Tuesday. The company is still waiting for an FDA decision on approval of their Ampligen treatment for Chronic Fatigue Syndrome shot up from $1.74 and established a new 52-week high at $2.57 before profit taking took the
stock back to a close of $2.28. Shares were trading even after hours as investor await the eagerly antcipated news.

The company announced yesterday an invitation, funded entirely by the government of Italy, to present its technology platform for influenza control, at the upcoming "International Conference on Biotechnologies and Finance" in Rome on July 4-5, 2009,

See the rest of Tuesday's movers in healthcare below. 

Top Movers In Health Care

Tuesday, June 2, 2009
Hemispherx BioPharma, Inc HEB 2.28 +0.57 (33.33%) 194.09M
Orexigen Therapeutics OREX 4.37 +0.75 (20.72%) 151.47M
Nymox Pharmaceutical Corp NYMX 3.65 +0.45 (14.06%) 111.56M
XenoPort, Inc. XNPT 20.71 +2.21 (11.95%) 565.62M
Stereotaxis, Inc. STXS 4.13 +0.39 (10.43%) 175.02M

Losers (% price change)

Cardinal Health, Inc. CAH 32.60 -3.96 (-10.83%) 11.75B
Brookdale Senior Living BKD 11.20 -1.15 (-9.31%) 1.14B
Insulet Corporation PODD 7.15 -0.68 (-8.68%) 199.15M
Nutraceutical Int'l Corp. NUTR 9.32 -0.78 (-7.72%) 101.54M
Kindred Healthcare, Inc. KND 12.30 -1.01 (-7.59%) 479.77M

Most Actives (dollar volume)

Pfizer Inc. PFE 14.98 +0.22 (1.49%) 101.08B
Johnson & Johnson JNJ 56.21 +0.43 (0.77%) 154.89B
Baxter International Inc. BAX 48.19 -1.04 (-2.11%) 29.16B
Wyeth WYE 45.00 +0.31 (0.69%) 60.01B
Cardinal Health, Inc. CAH 32.60 -3.96 (-10.83%)

11.75B




BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!

blog comments powered by Disqus
 
BMR:1